| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |